# The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC)

> **NCT02839668** · PHASE2 · COMPLETED · sponsor: **Iuliu Hatieganu University of Medicine and Pharmacy** · enrollment: 120 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Sevoflurane
- **DRUG:** TIVA-TCI
- **DRUG:** Acetaminophen
- **DRUG:** Tramadol
- **DRUG:** Neostigmine
- **DRUG:** Atropine
- **DEVICE:** BIS

## Key facts

- **NCT ID:** NCT02839668
- **Lead sponsor:** Iuliu Hatieganu University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2019-09
- **Final completion:** 2019-09
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02839668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02839668, "The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02839668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*